Anzeige
❌
Mehr »
Donnerstag, 29.10.2026 - Börsentäglich über 12.000 News
Der nächste Bergbau-Boom, von dem noch niemand etwas weiß
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
241 Leser
Artikel bewerten:
(0)

A view into SNOMED CT's globally recognized clinical terminology with the release of SNOMED International's Global Patient Set

London, United Kingdom, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Picture an elderly patient navigating orthopaedic care across primary, acute and rehabilitative sectors; a woman moving through breast cancer diagnosis and treatment in a developing digital health environment; or gathering critical patient information in the midst of a conflict, epidemic or disaster. These scenarios represent instances in which the Global Patient Set (GPS) can make an impact in non-SNOMED CT enabled countries.

A slice of SNOMED CT, the GPS is a managed collection of existing reference sets, available to any user at no cost. The GPS offers clinical content across dentistry, renal, family & general practice and nursing areas, and includes IHE, DICOMand HL7 International Patient Summarydomains and activities. SNOMED International's General Assembly Chair, Lies van Gennip, is encouraged by what the GPS represents, including easier specification of EHR requirements through clinical documents such as a patient summary. Van Gennip shares, "The GPS is a step towards increased clinical information sharing across borders, bridging the interoperability divide through the use of structured terminology."

Those not presently engaged in SNOMED International membership or party to an affiliate license have the most to gain from the GPS. The GPS can support the nascent use of clinical terminology within a developing health system, the sharing of patient summary information across borders with existing SNOMED International Member countries or affiliates, as well as promoting use in specification development and research. CEO Don Sweete offers, "The impetus driving the GPS is to introduce a facet of SNOMED CT's global terminology where it can be put to good use, whether that's supporting cross border interoperability or enhancing digital maturity." SNOMED International has elaborated on these use cases, or scenarios, and has made them openly available.

The GPS contains SNOMED CT unique identifiers, fully specified names, preferred terms in international English, and status flags. While valuable in many ways to various healthcare actors and their supporting digital environments, it's important to note that the GPS as a whole is not a clinically curated list; it excludes SNOMED CT's inherent relationships and hierarchies; fundamental to the nature of an ontology and its ability to enable clinical data analytics, decision support, and power artificial intelligence, etc. The complete set of concept synonyms and definitions are also not part of the GPS.

Chief among the benefits of SNOMED International membership includes access to terminology that enables interoperability, reduced clinical risk, large scale public health reporting and research, and a wealth of organization resources including education, tooling, creation of national extensions, representation on governance bodies, and dedicated on-boarding and user support.

Offered under the Creative Commons Attribution 4.0 International Public License, the GPS is available to any interested party, at no cost, simply by visiting SNOMED International's GPS information pageand registering your use. The GPS will be updated and released annually to reflect changes to the underlying terminology, including concept inactivations and additions. Implementation guidance has been created and can be found as part of the GPS file as well as on SNOMED International's GPS information page.

For more information on this exciting product, contact gps@snomed.org.


About SNOMED International

SNOMED International is a not-for-profit organization that owns and develops SNOMED CT, theworld's most comprehensive healthcare terminology product. We play an essential role inimproving the health of humankind by determining standards for a codified language thatrepresents groups of clinical terms. This enables healthcare information to be exchangedglobally for the benefit of patients and other stakeholders. We are committed to the rigorousevolution of our products and services, to deliver continuous innovation for the global healthcarecommunity. SNOMED International is the trading name of the International Health TerminologyStandards Development Organisation

Attachment

  • Global Patient Set (https://ml.globenewswire.com/Resource/Download/f4fedc5d-a90f-45e1-8b62-72ba6406e21a)
© 2019 GlobeNewswire (Europe)
Historische Öl-Krise - 5 Aktien, die davon profitieren!
Der Iran-Krieg hat den globalen Energiemarkt erschüttert. Zerstörte Förderanlagen, ausgefallene Transportwege und fehlende Raffineriekapazitäten sorgen dafür, dass nicht nur Rohöl, sondern vor allem Benzin und Diesel knapp und teuer bleiben könnten. Selbst ein Ende der Kämpfe würde das Problem nicht über Nacht lösen, der Wiederaufbau der Energieinfrastruktur dürfte Jahre dauern.

Während viele Anleger jetzt auf ExxonMobil, Chevron oder Shell setzen, könnte das größere Potenzial längst woanders liegen. Denn hohe Ölpreise machen neue Investitionen in Förderung, Transport und Verarbeitung wieder attraktiv. Davon profitieren vor allem jene Unternehmen, die Bohrtechnik, Ausrüstung und Dienstleistungen bereitstellen oder bereits über wertvolle Infrastruktur verfügen.

Hier dürfte die zweite Welle des Öl-Booms entstehen. Statt den bereits stark gelaufenen Produzenten hinterherzulaufen, können Anleger auf die Unternehmen setzen, die am milliardenschweren Wiederaufbau der globalen Energieinfrastruktur verdienen.

In unserem aktuellen Spezialreport zeigen wir 5 Aktien, die von der historischen Öl-Krise besonders profitieren könnten.

Jetzt den kostenlosen Report sichern und die möglichen Gewinner der zweiten Öl-Welle entdecken!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.